Advancing Pre-Market Safety Analytics

Due to a lack of standardization of safety data analysis and visualization, inconsistencies are noted in how adverse events are defined, categorized, analyzed, and presented in marketing applications. The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research’s Office of...

Due to a lack of standardization of safety data analysis and visualization, inconsistencies are...

Read More